Donald C. Aroborgast

Prior to joining Pearl Street, Mr. Aroborgast retired from Eli Lilly and Company as Director of Corporate Risk Management and Insurance.
Particular expertise in assessing risk and crafting insurance solutions that integrate clinician's liability, professional liability, clinical trial coverage issues and corporate liability issues in the pharmaceutical industry.
Serves on the boards of several life science companies including NNC Group, LLC and Geist Pharmaceuticals, LLC.
Mr. Aroborgast has a BS degree from the University of Florida and a JD from the Nashville Law School, Nashville, Tennessee.